Aging-associated increase of GATA4 levels in articular cartilage is linked to impaired regenerative capacity of chondrocytes and osteoarthritis

Aging is strongly associated with the development of osteoarthritis (OA), yet the precise mechanisms remain unclear. Researchers sought to uncover the regulatory factors that distinguish chondrocytes in young and elderly individuals. Through the examination of gene expression in human and mouse articular cartilage, the team identified that the GATA-binding protein 4 (GATA4) may be a crucial regulator of aging-related changes in chondrocytes.

Both immunostaining and western blot analysis revealed significantly higher levels of GATA4 in older chondrocytes, compared to their younger counterparts. Furthermore, the introduction of additional GATA4 in young chondrocytes severely reduced their ability to form cartilage in laboratory settings, while also causing an increase in the production of proinflammatory cytokines.

Conversely, lowering GATA4 expression in aged chondrocytes, through either RNA interference or a small molecule inhibitor, led to higher levels of cartilage-forming molecules, such as aggrecan and collagen type II, and a decrease in enzymes that break down cartilage.

In a mouse model of OA, induced by the surgical destabilization of the medial meniscus, intra-articular injection of a lentiviral vector carrying mouse GATA4 genes resulted in a more severe OA, along with increased synovial inflammation and pain levels, compared to those injected with a control vector. The researchers discovered that overexpression of GATA4 led to increased phosphorylation of SMAD1/5, a signaling pathway known to play a role in chondrocyte function.

In conclusion, the study demonstrates that an increase in GATA4 levels in chondrocytes during aging plays a critical role in the progression of OA. The findings suggest that targeting this molecular pathway could potentially reduce the incidence and severity of OA in the aging population.